دورية أكاديمية
Chemonucleolysis combined with dynamic loading for inducing degeneration in bovine caudal intervertebral discs.
| العنوان: | Chemonucleolysis combined with dynamic loading for inducing degeneration in bovine caudal intervertebral discs. |
|---|---|
| المؤلفون: | Vernengo A; AO Research Institute Davos, Davos, Switzerland., Bumann H; AO Research Institute Davos, Davos, Switzerland., Kluser N; AO Research Institute Davos, Davos, Switzerland., Soubrier A; AO Research Institute Davos, Davos, Switzerland., Šećerović A; AO Research Institute Davos, Davos, Switzerland., Gewiess J; AO Research Institute Davos, Davos, Switzerland., Jansen JU; Institute of Orthopaedic Research and Biomechanics, Ulm University, Ulm, Germany., Neidlinger-Wilke C; Institute of Orthopaedic Research and Biomechanics, Ulm University, Ulm, Germany., Wilke HJ; Institute of Orthopaedic Research and Biomechanics, Ulm University, Ulm, Germany., Grad S; AO Research Institute Davos, Davos, Switzerland.; Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland. |
| المصدر: | Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2023 Aug 30; Vol. 11, pp. 1178938. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101632513 Publication Model: eCollection Cited Medium: Print ISSN: 2296-4185 (Print) Linking ISSN: 22964185 NLM ISO Abbreviation: Front Bioeng Biotechnol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Media S.A., [2013]- |
| مستخلص: | Chemonucleolysis has become an established method of producing whole organ culture models of intervertebral disc (IVD) degeneration. However, the field needs more side-by-side comparisons of the degenerative effects of the major enzymes used in chemonucleolysis towards gaining a greater understanding of how these organ culture models mimic the wide spectrum of characteristics observed in human degeneration. In the current work we induced chemonucleolysis in bovine coccygeal IVDs with 100 µL of papain (65 U/mL), chondroitinase ABC (chABC, 5 U/mL), or collagenase II (col'ase, 0.5 U/mL). Each enzyme was applied in a concentration projected to produce moderate levels of degeneration. After 7 days of culture with daily dynamic physiological loading (0.02-0.2 MPa, 0.2 Hz, 2 h), the cellular, biochemical and histological properties of the IVDs were evaluated in comparison to a PBS-injected control. Papain and collagenase, but not chABC, produced macroscopic voids in the tissues. Compared to day 0 intact IVDs, papain induced the greatest magnitude glycosaminoglycan (GAG) loss compared to chABC and col'ase. Papain also induced the greatest height loss (3%), compared to 0.7%, 1.2% and 0.4% for chABC, col'ase, and PBS, respectively. Cell viability in the region adjacent to papain and PBS-injection remained at nearly 100% over the 7-day culture period, whereas it was reduced to 60%-70% by chABC and col'ase. Generally, enzyme treatment tended to downregulate gene expression for major ECM markers, type I collagen (COL1), type II collagen (COL2), and aggrecan (ACAN) in the tissue adjacent to injection. However, chABC treatment induced an increase in COL2 gene expression, which was significant compared to the papain treated group. In general, papain and col'ase treatment tended to recapitulate aspects of advanced IVD degeneration, whereas chABC treatment captured aspects of early-stage degeneration. Chemonucleolysis of whole bovine IVDs is a useful tool providing researchers with a robust spectrum of degenerative changes and can be utilized for examination of therapeutic interventions. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Vernengo, Bumann, Kluser, Soubrier, Šećerović, Gewiess, Jansen, Neidlinger-Wilke, Wilke and Grad.) |
| References: | Asian Spine J. 2020 Apr;14(2):245-257. (PMID: 31679325) J Biol Chem. 2003 Nov 14;278(46):45539-45. (PMID: 12890681) JOR Spine. 2020 Jun 19;3(3):e1104. (PMID: 33015577) J Cell Physiol. 2021 Nov;236(11):7504-7515. (PMID: 33821497) Handb Clin Neurol. 2016;136:675-88. (PMID: 27430435) J Neurosurg. 1976 Jan;44(1):32-44. (PMID: 172611) J Orthop Res. 2020 Nov;38(11):2521-2531. (PMID: 32091156) Spine (Phila Pa 1976). 2007 May 15;32(11):1181-7. (PMID: 17495774) Biomed Pharmacother. 2023 Jun;162:114711. (PMID: 37084562) Eur Cell Mater. 2020 Nov 18;40:239-258. (PMID: 33206993) Arthritis Rheum. 2009 Feb;60(2):482-91. (PMID: 19180493) Biomed Res Int. 2016;2016:5952165. (PMID: 27314030) Arch Orthop Trauma Surg. 1997;116(1-2):106-7. (PMID: 9006777) Acta Biomater. 2019 Mar 1;86:300-311. (PMID: 30660009) Spine (Phila Pa 1976). 2002 Oct 15;27(20):2212-9. (PMID: 12394896) FASEB J. 2021 Nov;35(11):e21919. (PMID: 34591994) Matrix Biol. 2018 Oct;71-72:368-379. (PMID: 29501510) PLoS One. 2012;7(3):e33147. (PMID: 22427972) Cell Death Discov. 2019 Dec 17;5:154. (PMID: 31871771) Spine J. 2013 Mar;13(3):273-83. (PMID: 23353003) Arthritis Res Ther. 2013;15(5):R121. (PMID: 24171898) Spine (Phila Pa 1976). 2010 Mar 1;35(5):531-6. (PMID: 20147869) Spine (Phila Pa 1976). 2018 Feb 15;43(4):E208-E215. (PMID: 28719551) Spine (Phila Pa 1976). 2008 Feb 1;33(3):235-41. (PMID: 18303454) Spine (Phila Pa 1976). 2002 May 1;27(9):911-7. (PMID: 11979160) Sci Rep. 2016 Sep 19;6:33270. (PMID: 27641507) Neurosurgery. 2017 Mar 01;80(3S):S46-S54. (PMID: 28350945) J Orthop Res. 1997 Jul;15(4):528-38. (PMID: 9379262) J Orthop Translat. 2022 Nov 05;37:163-172. (PMID: 36380883) Clin Sci (Lond). 2017 May 1;131(10):965-979. (PMID: 28341660) BMC Musculoskelet Disord. 2008 Feb 25;9:24. (PMID: 18298830) Cell Mol Bioeng. 2009 Sep 1;2(3):437-447. (PMID: 21179399) JOR Spine. 2021 Jun 14;4(2):e1162. (PMID: 34337336) Biochem Soc Trans. 2007 Aug;35(Pt 4):652-5. (PMID: 17635113) Acta Biomater. 2021 Sep 1;131:117-127. (PMID: 34229105) Oxid Med Cell Longev. 2020 Aug 31;2020:9503562. (PMID: 32934764) J Mech Behav Biomed Mater. 2017 May;69:30-38. (PMID: 28033533) J Tissue Eng Regen Med. 2015 Dec;9(12):E167-76. (PMID: 23303720) J Spinal Disord Tech. 2014 Jul;27(5):E168-75. (PMID: 24513662) Spine (Phila Pa 1976). 2006 Nov 1;31(23):2665-73. (PMID: 17077734) Arthritis Res Ther. 2003;5(3):120-30. (PMID: 12723977) J Biomech Eng. 2013 Jun;135(6):61004-5. (PMID: 23699716) J Pathol. 2004 Sep;204(1):47-54. (PMID: 15307137) Artif Cells Nanomed Biotechnol. 2018;46(sup2):182-191. (PMID: 30056756) Clin Biomech (Bristol, Avon). 2020 Mar;73:149-156. (PMID: 31986460) Eur Cell Mater. 2006 Aug 03;12:16-25; discussion 16-25. (PMID: 16888702) Eur Cell Mater. 2020 Jul 16;40:21-37. (PMID: 32672345) JOR Spine. 2021 Jun 01;4(3):e1161. (PMID: 34611588) Connect Tissue Res. 2020 May-Jul;61(3-4):304-321. (PMID: 31556329) J Orthop Res. 2004 Nov;22(6):1193-200. (PMID: 15475197) Osteoarthritis Cartilage. 2017 Jan;25(1):146-156. (PMID: 27568573) Theranostics. 2019 May 31;9(14):4084-4100. (PMID: 31281533) Mol Med Rep. 2017 Oct;16(4):4730-4736. (PMID: 28791354) J Tissue Eng Regen Med. 2018 Apr;12(4):e2051-e2061. (PMID: 29320615) Biochemistry. 1985 Nov 5;24(23):6520-6. (PMID: 3002445) Eur Cell Mater. 2014 Sep 12;28:98-110; discussion 110-1. (PMID: 25214017) JAMA. 1980 May 23-30;243(20):2043-8. (PMID: 6990025) J Orthop Res. 1993 May;11(3):332-8. (PMID: 8326439) Eur Spine J. 2017 Aug;26(8):2053-2062. (PMID: 28567592) Spine (Phila Pa 1976). 2006 Mar 1;31(5):510-4. (PMID: 16508543) Ann N Y Acad Sci. 2007 Jan;1096:239-48. (PMID: 17405935) Rheumatol Rehabil. 1977 Feb;16(1):22-9. (PMID: 847321) Clin Chim Acta. 2015 Aug 25;448:238-46. (PMID: 26162271) Arthritis Res Ther. 2007;9(3):R45. (PMID: 17498290) Connect Tissue Res. 2001;42(3):197-207. (PMID: 11913491) AJNR Am J Neuroradiol. 2015 Dec;36(12):2394-9. (PMID: 26359154) Sci Rep. 2021 Jan 12;11(1):772. (PMID: 33437038) Rheumatology (Oxford). 2009 Jan;48(1):5-10. (PMID: 18854342) Eur Spine J. 2008 Jan;17(1):2-19. (PMID: 17632738) Spine (Phila Pa 1976). 2000 Dec 1;25(23):3005-13. (PMID: 11145811) JOR Spine. 2022 Jul 11;5(3):e1216. (PMID: 36203865) Spine (Phila Pa 1976). 2002 Dec 1;27(23):2631-44. (PMID: 12461389) Spine (Phila Pa 1976). 1988 Feb;13(2):173-8. (PMID: 3406837) Biomacromolecules. 2020 Dec 14;21(12):4795-4805. (PMID: 32955865) Spine J. 2021 Aug;21(8):1387-1398. (PMID: 33872805) Spine (Phila Pa 1976). 2007 May 15;32(11):1197-205. (PMID: 17495776) J Orthop Translat. 2020 Oct 20;26:141-150. (PMID: 33437633) JOR Spine. 2018 Jun 19;1(2):e1017. (PMID: 31463444) J Biomech. 2020 Dec 2;113:110100. (PMID: 33142205) |
| فهرسة مساهمة: | Keywords: chemonucleolysis (CN); degeneration; extracellular matrix; intervertebral disc; organ culture |
| تواريخ الأحداث: | Date Created: 20230915 Latest Revision: 20230917 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC10499327 |
| DOI: | 10.3389/fbioe.2023.1178938 |
| PMID: | 37711456 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2296-4185 |
|---|---|
| DOI: | 10.3389/fbioe.2023.1178938 |